re NKBS in the Q2 cc forecast a weak Q3 followed by a strong Q4 .... maybe Q3 results will even show a loss. The decline in the stock price has been relentless, even after that recently announced agreement with UBS which should boost business.
Stock is now trading at $1.78, well below tangible book value of about $2.12.
I'm still holding all my shares, but too concerned about the weak chart to add any more ....